Circulating stem cells – waxing hematopoietic

Margaret Anne Kessinger

Research output: Contribution to journalEditorial

15 Citations (Scopus)

Abstract

During the development of the human embryo, hematopoietic cells first appear in the yolk sac, then migrate to the liver and from there to the bone marrow through the bloodstream. Until the 1970s, it was assumed that these cells resided exclusively in the bone marrow, but then hematopoietic cells capable of mitosis were identified in the blood of laboratory animals and humans.1,2 Before that, all normal blood cells were considered to be terminally differentiated, moving to the circulation only after they had completed a series of maturational mitoses in the marrow. Investigators wondered whether these newly found mitotic blood.

Original languageEnglish (US)
Pages (from-to)315-317
Number of pages3
JournalNew England Journal of Medicine
Volume333
Issue number5
DOIs
StatePublished - Aug 3 1995

Fingerprint

Hematopoietic Stem Cells
Bone Marrow
Mitosis
Yolk Sac
Laboratory Animals
Human Development
Embryonic Development
Blood Cells
Research Personnel
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Circulating stem cells – waxing hematopoietic. / Kessinger, Margaret Anne.

In: New England Journal of Medicine, Vol. 333, No. 5, 03.08.1995, p. 315-317.

Research output: Contribution to journalEditorial

Kessinger, Margaret Anne. / Circulating stem cells – waxing hematopoietic. In: New England Journal of Medicine. 1995 ; Vol. 333, No. 5. pp. 315-317.
@article{b85d9a0f9e0d47aa9173dbc808806b48,
title = "Circulating stem cells – waxing hematopoietic",
abstract = "During the development of the human embryo, hematopoietic cells first appear in the yolk sac, then migrate to the liver and from there to the bone marrow through the bloodstream. Until the 1970s, it was assumed that these cells resided exclusively in the bone marrow, but then hematopoietic cells capable of mitosis were identified in the blood of laboratory animals and humans.1,2 Before that, all normal blood cells were considered to be terminally differentiated, moving to the circulation only after they had completed a series of maturational mitoses in the marrow. Investigators wondered whether these newly found mitotic blood.",
author = "Kessinger, {Margaret Anne}",
year = "1995",
month = "8",
day = "3",
doi = "10.1056/NEJM199508033330512",
language = "English (US)",
volume = "333",
pages = "315--317",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "5",

}

TY - JOUR

T1 - Circulating stem cells – waxing hematopoietic

AU - Kessinger, Margaret Anne

PY - 1995/8/3

Y1 - 1995/8/3

N2 - During the development of the human embryo, hematopoietic cells first appear in the yolk sac, then migrate to the liver and from there to the bone marrow through the bloodstream. Until the 1970s, it was assumed that these cells resided exclusively in the bone marrow, but then hematopoietic cells capable of mitosis were identified in the blood of laboratory animals and humans.1,2 Before that, all normal blood cells were considered to be terminally differentiated, moving to the circulation only after they had completed a series of maturational mitoses in the marrow. Investigators wondered whether these newly found mitotic blood.

AB - During the development of the human embryo, hematopoietic cells first appear in the yolk sac, then migrate to the liver and from there to the bone marrow through the bloodstream. Until the 1970s, it was assumed that these cells resided exclusively in the bone marrow, but then hematopoietic cells capable of mitosis were identified in the blood of laboratory animals and humans.1,2 Before that, all normal blood cells were considered to be terminally differentiated, moving to the circulation only after they had completed a series of maturational mitoses in the marrow. Investigators wondered whether these newly found mitotic blood.

UR - http://www.scopus.com/inward/record.url?scp=0029076174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029076174&partnerID=8YFLogxK

U2 - 10.1056/NEJM199508033330512

DO - 10.1056/NEJM199508033330512

M3 - Editorial

VL - 333

SP - 315

EP - 317

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 5

ER -